Review





Similar Products

94
ATCC human fecal dna
Human Fecal Dna, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human fecal dna/product/ATCC
Average 94 stars, based on 1 article reviews
human fecal dna - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

93
Jena Bioscience genomic dna
Genomic Dna, supplied by Jena Bioscience, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/genomic dna/product/Jena Bioscience
Average 93 stars, based on 1 article reviews
genomic dna - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

85
ATCC cross reactivity test results sample name n1 ct n2 ct n3 ct source concentration adenovirus 11 n d n d n d atcc vr 12d
Cross Reactivity Test Results Sample Name N1 Ct N2 Ct N3 Ct Source Concentration Adenovirus 11 N D N D N D Atcc Vr 12d, supplied by ATCC, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cross reactivity test results sample name n1 ct n2 ct n3 ct source concentration adenovirus 11 n d n d n d atcc vr 12d/product/ATCC
Average 85 stars, based on 1 article reviews
cross reactivity test results sample name n1 ct n2 ct n3 ct source concentration adenovirus 11 n d n d n d atcc vr 12d - by Bioz Stars, 2026-02
85/100 stars
  Buy from Supplier

85
ATCC adenovirus 5 n d n d n d atcc vr 5d
Adenovirus 5 N D N D N D Atcc Vr 5d, supplied by ATCC, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/adenovirus 5 n d n d n d atcc vr 5d/product/ATCC
Average 85 stars, based on 1 article reviews
adenovirus 5 n d n d n d atcc vr 5d - by Bioz Stars, 2026-02
85/100 stars
  Buy from Supplier

95
Zymo Research fully methylated human genomic dna
Schematic and performance of the tMCTA-seq method (A) The tMCTA-seq begins with bisulfite treatment, converting unmethylated CpG tandems in CGIs to UpG tandems, leaving <t>methylated</t> CGIs unaffected. In the first step, primer A, which comprises a semi-random sequence with a CpG site at the 3′-end, a unique molecular identifier (UMI) sequence in the middle, and an anchor sequence at the 5′-end, anneals semi-randomly to converted <t>DNA</t> and extends. This step preferentially amplifies methylated CGIs due to their higher density of methylated CpG sites. Next, a set of locus-specific primers is used for targeted amplification in combination with primer TA (sharing partial sequence homology with primer A). Primer B, containing the “CGCGCGG” sequence, serves as a universal inner nested primer to selectively amplify methylated CpG tandem sites. Finally, indexed primers C and D were employed for PCR amplification to generate the sequencing library. (B) The input and captured molecules of 110 mCGCGCGG-CpG (upper: enlarged view of the dashed areas). The FMG was diluted from 150 pg (equivalent to 110 × 150 ÷ 3.3 = 5,000 molecules for the total 110 sites) down to 2.3 pg (equivalent to 110 × 2.3 ÷ 3.3 = 77 molecules for the total 110 sites) and spiked into 6 ng of WBC <t>gDNA.</t> (C) The captured molecules, and (D) sequencing depth of 110 mCGCGCGG-CpGs in MCTA-seq and tMCTA-seq, with 150 pg of FMGs spiked into 6 ng of WBC gDNA. Data are represented as the mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, two-tailed Mann–Whitney-Wilcoxon test.
Fully Methylated Human Genomic Dna, supplied by Zymo Research, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fully methylated human genomic dna/product/Zymo Research
Average 95 stars, based on 1 article reviews
fully methylated human genomic dna - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

95
Zymo Research methylated human genomic dna
Schematic and performance of the tMCTA-seq method (A) The tMCTA-seq begins with bisulfite treatment, converting unmethylated CpG tandems in CGIs to UpG tandems, leaving <t>methylated</t> CGIs unaffected. In the first step, primer A, which comprises a semi-random sequence with a CpG site at the 3′-end, a unique molecular identifier (UMI) sequence in the middle, and an anchor sequence at the 5′-end, anneals semi-randomly to converted <t>DNA</t> and extends. This step preferentially amplifies methylated CGIs due to their higher density of methylated CpG sites. Next, a set of locus-specific primers is used for targeted amplification in combination with primer TA (sharing partial sequence homology with primer A). Primer B, containing the “CGCGCGG” sequence, serves as a universal inner nested primer to selectively amplify methylated CpG tandem sites. Finally, indexed primers C and D were employed for PCR amplification to generate the sequencing library. (B) The input and captured molecules of 110 mCGCGCGG-CpG (upper: enlarged view of the dashed areas). The FMG was diluted from 150 pg (equivalent to 110 × 150 ÷ 3.3 = 5,000 molecules for the total 110 sites) down to 2.3 pg (equivalent to 110 × 2.3 ÷ 3.3 = 77 molecules for the total 110 sites) and spiked into 6 ng of WBC <t>gDNA.</t> (C) The captured molecules, and (D) sequencing depth of 110 mCGCGCGG-CpGs in MCTA-seq and tMCTA-seq, with 150 pg of FMGs spiked into 6 ng of WBC gDNA. Data are represented as the mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, two-tailed Mann–Whitney-Wilcoxon test.
Methylated Human Genomic Dna, supplied by Zymo Research, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/methylated human genomic dna/product/Zymo Research
Average 95 stars, based on 1 article reviews
methylated human genomic dna - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

93
ATCC ht 29 m6
Schematic and performance of the tMCTA-seq method (A) The tMCTA-seq begins with bisulfite treatment, converting unmethylated CpG tandems in CGIs to UpG tandems, leaving <t>methylated</t> CGIs unaffected. In the first step, primer A, which comprises a semi-random sequence with a CpG site at the 3′-end, a unique molecular identifier (UMI) sequence in the middle, and an anchor sequence at the 5′-end, anneals semi-randomly to converted <t>DNA</t> and extends. This step preferentially amplifies methylated CGIs due to their higher density of methylated CpG sites. Next, a set of locus-specific primers is used for targeted amplification in combination with primer TA (sharing partial sequence homology with primer A). Primer B, containing the “CGCGCGG” sequence, serves as a universal inner nested primer to selectively amplify methylated CpG tandem sites. Finally, indexed primers C and D were employed for PCR amplification to generate the sequencing library. (B) The input and captured molecules of 110 mCGCGCGG-CpG (upper: enlarged view of the dashed areas). The FMG was diluted from 150 pg (equivalent to 110 × 150 ÷ 3.3 = 5,000 molecules for the total 110 sites) down to 2.3 pg (equivalent to 110 × 2.3 ÷ 3.3 = 77 molecules for the total 110 sites) and spiked into 6 ng of WBC <t>gDNA.</t> (C) The captured molecules, and (D) sequencing depth of 110 mCGCGCGG-CpGs in MCTA-seq and tMCTA-seq, with 150 pg of FMGs spiked into 6 ng of WBC gDNA. Data are represented as the mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, two-tailed Mann–Whitney-Wilcoxon test.
Ht 29 M6, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ht 29 m6/product/ATCC
Average 93 stars, based on 1 article reviews
ht 29 m6 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

94
ATCC human dna standard
a) We conducted a serial dilution experiment in which we mixed <t>two</t> <t>Mtb</t> <t>DNA</t> standards representing lineage 4.1.2.1 (strain X003899) and 4.9 (strain H37ra), such that the minority strain represented 0-100% of the total DNA and then diluted Mtb DNA in human DNA, to simulate clinical samples which are overwhelmingly human DNA. We approximated the proportion of Mtb DNA found in sputum with smear microscopy grades 1+, 2+, and 3+. 7 We used hybrid capture to enrich for Mtb DNA, conducted whole genome sequencing of captured libraries on an Illumina platform. b) We additionally prospectively sampled matched Mtb diagnostic cultures and unprocessed sputum submitted to ARUP diagnostic laboratories. We performed hybrid capture and Illumina whole genome sequencing on matched samples.
Human Dna Standard, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human dna standard/product/ATCC
Average 94 stars, based on 1 article reviews
human dna standard - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

Image Search Results


Schematic and performance of the tMCTA-seq method (A) The tMCTA-seq begins with bisulfite treatment, converting unmethylated CpG tandems in CGIs to UpG tandems, leaving methylated CGIs unaffected. In the first step, primer A, which comprises a semi-random sequence with a CpG site at the 3′-end, a unique molecular identifier (UMI) sequence in the middle, and an anchor sequence at the 5′-end, anneals semi-randomly to converted DNA and extends. This step preferentially amplifies methylated CGIs due to their higher density of methylated CpG sites. Next, a set of locus-specific primers is used for targeted amplification in combination with primer TA (sharing partial sequence homology with primer A). Primer B, containing the “CGCGCGG” sequence, serves as a universal inner nested primer to selectively amplify methylated CpG tandem sites. Finally, indexed primers C and D were employed for PCR amplification to generate the sequencing library. (B) The input and captured molecules of 110 mCGCGCGG-CpG (upper: enlarged view of the dashed areas). The FMG was diluted from 150 pg (equivalent to 110 × 150 ÷ 3.3 = 5,000 molecules for the total 110 sites) down to 2.3 pg (equivalent to 110 × 2.3 ÷ 3.3 = 77 molecules for the total 110 sites) and spiked into 6 ng of WBC gDNA. (C) The captured molecules, and (D) sequencing depth of 110 mCGCGCGG-CpGs in MCTA-seq and tMCTA-seq, with 150 pg of FMGs spiked into 6 ng of WBC gDNA. Data are represented as the mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, two-tailed Mann–Whitney-Wilcoxon test.

Journal: iScience

Article Title: A targeted DNA methylation method for detecting gastrointestinal cancer in circulating cell-free DNA

doi: 10.1016/j.isci.2025.114342

Figure Lengend Snippet: Schematic and performance of the tMCTA-seq method (A) The tMCTA-seq begins with bisulfite treatment, converting unmethylated CpG tandems in CGIs to UpG tandems, leaving methylated CGIs unaffected. In the first step, primer A, which comprises a semi-random sequence with a CpG site at the 3′-end, a unique molecular identifier (UMI) sequence in the middle, and an anchor sequence at the 5′-end, anneals semi-randomly to converted DNA and extends. This step preferentially amplifies methylated CGIs due to their higher density of methylated CpG sites. Next, a set of locus-specific primers is used for targeted amplification in combination with primer TA (sharing partial sequence homology with primer A). Primer B, containing the “CGCGCGG” sequence, serves as a universal inner nested primer to selectively amplify methylated CpG tandem sites. Finally, indexed primers C and D were employed for PCR amplification to generate the sequencing library. (B) The input and captured molecules of 110 mCGCGCGG-CpG (upper: enlarged view of the dashed areas). The FMG was diluted from 150 pg (equivalent to 110 × 150 ÷ 3.3 = 5,000 molecules for the total 110 sites) down to 2.3 pg (equivalent to 110 × 2.3 ÷ 3.3 = 77 molecules for the total 110 sites) and spiked into 6 ng of WBC gDNA. (C) The captured molecules, and (D) sequencing depth of 110 mCGCGCGG-CpGs in MCTA-seq and tMCTA-seq, with 150 pg of FMGs spiked into 6 ng of WBC gDNA. Data are represented as the mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, two-tailed Mann–Whitney-Wilcoxon test.

Article Snippet: Fully methylated human genomic DNA (FMG) , Zymo Research , D5014.

Techniques: Methylation, Sequencing, Amplification, Two Tailed Test, MANN-WHITNEY

Schematic and performance of the tMCTA-seq method (A) The tMCTA-seq begins with bisulfite treatment, converting unmethylated CpG tandems in CGIs to UpG tandems, leaving methylated CGIs unaffected. In the first step, primer A, which comprises a semi-random sequence with a CpG site at the 3′-end, a unique molecular identifier (UMI) sequence in the middle, and an anchor sequence at the 5′-end, anneals semi-randomly to converted DNA and extends. This step preferentially amplifies methylated CGIs due to their higher density of methylated CpG sites. Next, a set of locus-specific primers is used for targeted amplification in combination with primer TA (sharing partial sequence homology with primer A). Primer B, containing the “CGCGCGG” sequence, serves as a universal inner nested primer to selectively amplify methylated CpG tandem sites. Finally, indexed primers C and D were employed for PCR amplification to generate the sequencing library. (B) The input and captured molecules of 110 mCGCGCGG-CpG (upper: enlarged view of the dashed areas). The FMG was diluted from 150 pg (equivalent to 110 × 150 ÷ 3.3 = 5,000 molecules for the total 110 sites) down to 2.3 pg (equivalent to 110 × 2.3 ÷ 3.3 = 77 molecules for the total 110 sites) and spiked into 6 ng of WBC gDNA. (C) The captured molecules, and (D) sequencing depth of 110 mCGCGCGG-CpGs in MCTA-seq and tMCTA-seq, with 150 pg of FMGs spiked into 6 ng of WBC gDNA. Data are represented as the mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, two-tailed Mann–Whitney-Wilcoxon test.

Journal: iScience

Article Title: A targeted DNA methylation method for detecting gastrointestinal cancer in circulating cell-free DNA

doi: 10.1016/j.isci.2025.114342

Figure Lengend Snippet: Schematic and performance of the tMCTA-seq method (A) The tMCTA-seq begins with bisulfite treatment, converting unmethylated CpG tandems in CGIs to UpG tandems, leaving methylated CGIs unaffected. In the first step, primer A, which comprises a semi-random sequence with a CpG site at the 3′-end, a unique molecular identifier (UMI) sequence in the middle, and an anchor sequence at the 5′-end, anneals semi-randomly to converted DNA and extends. This step preferentially amplifies methylated CGIs due to their higher density of methylated CpG sites. Next, a set of locus-specific primers is used for targeted amplification in combination with primer TA (sharing partial sequence homology with primer A). Primer B, containing the “CGCGCGG” sequence, serves as a universal inner nested primer to selectively amplify methylated CpG tandem sites. Finally, indexed primers C and D were employed for PCR amplification to generate the sequencing library. (B) The input and captured molecules of 110 mCGCGCGG-CpG (upper: enlarged view of the dashed areas). The FMG was diluted from 150 pg (equivalent to 110 × 150 ÷ 3.3 = 5,000 molecules for the total 110 sites) down to 2.3 pg (equivalent to 110 × 2.3 ÷ 3.3 = 77 molecules for the total 110 sites) and spiked into 6 ng of WBC gDNA. (C) The captured molecules, and (D) sequencing depth of 110 mCGCGCGG-CpGs in MCTA-seq and tMCTA-seq, with 150 pg of FMGs spiked into 6 ng of WBC gDNA. Data are represented as the mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, two-tailed Mann–Whitney-Wilcoxon test.

Article Snippet: The fully methylated human genomic DNA (FMG) was purchased from Zymo Research (D5014).

Techniques: Methylation, Sequencing, Amplification, Two Tailed Test, MANN-WHITNEY

a) We conducted a serial dilution experiment in which we mixed two Mtb DNA standards representing lineage 4.1.2.1 (strain X003899) and 4.9 (strain H37ra), such that the minority strain represented 0-100% of the total DNA and then diluted Mtb DNA in human DNA, to simulate clinical samples which are overwhelmingly human DNA. We approximated the proportion of Mtb DNA found in sputum with smear microscopy grades 1+, 2+, and 3+. 7 We used hybrid capture to enrich for Mtb DNA, conducted whole genome sequencing of captured libraries on an Illumina platform. b) We additionally prospectively sampled matched Mtb diagnostic cultures and unprocessed sputum submitted to ARUP diagnostic laboratories. We performed hybrid capture and Illumina whole genome sequencing on matched samples.

Journal: medRxiv

Article Title: Optimizing culture-free approaches to recover high quality M. tuberculosis genomic variation

doi: 10.64898/2025.12.16.25342406

Figure Lengend Snippet: a) We conducted a serial dilution experiment in which we mixed two Mtb DNA standards representing lineage 4.1.2.1 (strain X003899) and 4.9 (strain H37ra), such that the minority strain represented 0-100% of the total DNA and then diluted Mtb DNA in human DNA, to simulate clinical samples which are overwhelmingly human DNA. We approximated the proportion of Mtb DNA found in sputum with smear microscopy grades 1+, 2+, and 3+. 7 We used hybrid capture to enrich for Mtb DNA, conducted whole genome sequencing of captured libraries on an Illumina platform. b) We additionally prospectively sampled matched Mtb diagnostic cultures and unprocessed sputum submitted to ARUP diagnostic laboratories. We performed hybrid capture and Illumina whole genome sequencing on matched samples.

Article Snippet: We then diluted the Mtb DNA with a human DNA standard (HTB-22D, ATCC HTB-22), so that total Mtb DNA comprised a small proportion of total input DNA by molecular weight (0.01%, 0.03%, 0.3%), approximating the proportion of Mtb DNA found in sputum with smear microscopy grades 1+, 2+, and 3+.

Techniques: Serial Dilution, Microscopy, Sequencing, Diagnostic Assay

(a) The percentage of reads taxonomically classified to the Mycobacterium genus by Kraken, (b) the percentage of reads mapping to Mtb after filtering, and mean coverage. The x-axis for both (a, b, and c) indicates the percentage input Mtb DNA in the total DNA mixture and color indicates the proportion H37Ra (color). (d) Precision and recall (sensitivity) of SNP identification, by percentage of M. tuberculosis , for the samples comprised of 100% Lineage 4.1.2.1 (points) and 100% 4.9 (triangles). Colors indicate genomic region: outside PE/PPE genes, blue; within PE/PPE genes, red.

Journal: medRxiv

Article Title: Optimizing culture-free approaches to recover high quality M. tuberculosis genomic variation

doi: 10.64898/2025.12.16.25342406

Figure Lengend Snippet: (a) The percentage of reads taxonomically classified to the Mycobacterium genus by Kraken, (b) the percentage of reads mapping to Mtb after filtering, and mean coverage. The x-axis for both (a, b, and c) indicates the percentage input Mtb DNA in the total DNA mixture and color indicates the proportion H37Ra (color). (d) Precision and recall (sensitivity) of SNP identification, by percentage of M. tuberculosis , for the samples comprised of 100% Lineage 4.1.2.1 (points) and 100% 4.9 (triangles). Colors indicate genomic region: outside PE/PPE genes, blue; within PE/PPE genes, red.

Article Snippet: We then diluted the Mtb DNA with a human DNA standard (HTB-22D, ATCC HTB-22), so that total Mtb DNA comprised a small proportion of total input DNA by molecular weight (0.01%, 0.03%, 0.3%), approximating the proportion of Mtb DNA found in sputum with smear microscopy grades 1+, 2+, and 3+.

Techniques:

Proportion minor strain (expected minor allele frequency) versus observed minor allele frequency for minority variants identified, with columns indicating the percentage of Mtb DNA in the input DNA before hybrid capture and rows indicating genomic location. Colors indicate minor allele status.

Journal: medRxiv

Article Title: Optimizing culture-free approaches to recover high quality M. tuberculosis genomic variation

doi: 10.64898/2025.12.16.25342406

Figure Lengend Snippet: Proportion minor strain (expected minor allele frequency) versus observed minor allele frequency for minority variants identified, with columns indicating the percentage of Mtb DNA in the input DNA before hybrid capture and rows indicating genomic location. Colors indicate minor allele status.

Article Snippet: We then diluted the Mtb DNA with a human DNA standard (HTB-22D, ATCC HTB-22), so that total Mtb DNA comprised a small proportion of total input DNA by molecular weight (0.01%, 0.03%, 0.3%), approximating the proportion of Mtb DNA found in sputum with smear microscopy grades 1+, 2+, and 3+.

Techniques: